These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 31079831)
1. Gastroenteropancreatic neuroendocrine tumors: Role of surgery. Sauvanet A Ann Endocrinol (Paris); 2019 Jun; 80(3):175-181. PubMed ID: 31079831 [TBL] [Abstract][Full Text] [Related]
2. Surgery for GEP-NETs. Knigge U; Hansen CP Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):819-31. PubMed ID: 23582921 [TBL] [Abstract][Full Text] [Related]
3. Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy. Maekawa A; Kudo A; Kishino M; Murase Y; Watanabe S; Ishikawa Y; Ueda H; Akahoshi K; Ogawa K; Ono H; Tanaka S; Kinowaki Y; Tanabe M J Cancer Res Clin Oncol; 2022 Mar; 148(3):697-706. PubMed ID: 33904982 [TBL] [Abstract][Full Text] [Related]
4. A personal experience with pancreatic and duodenal neuroendocrine tumors. Jordan PH J Am Coll Surg; 1999 Nov; 189(5):470-82. PubMed ID: 10549736 [TBL] [Abstract][Full Text] [Related]
5. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors. Partelli S; Maurizi A; Tamburrino D; Baldoni A; Polenta V; Crippa S; Falconi M Eur J Endocrinol; 2014 Oct; 171(4):R153-62. PubMed ID: 24920289 [TBL] [Abstract][Full Text] [Related]
6. Determinants of surgical resection for pancreatic neuroendocrine tumors. Doi R J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163 [TBL] [Abstract][Full Text] [Related]
7. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target. Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545 [TBL] [Abstract][Full Text] [Related]
8. Surgical management of neuroendocrine tumors. Tamburrino D; Spoletini G; Partelli S; Muffatti F; Adamenko O; Crippa S; Falconi M Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):93-102. PubMed ID: 26971846 [TBL] [Abstract][Full Text] [Related]
9. Tumour grade and primary site predict patterns of recurrence and survival in patients with resected gastroenteropancreatic neuroendocrine tumors. Watanabe A; Yip L; Hamilton TD; Loree JM; Stuart HC Am J Surg; 2021 Jun; 221(6):1141-1149. PubMed ID: 33795127 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis. Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008 [TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors]. Kianmanesh R; O'toole D; Sauvanet A; Ruszniewski P; Belghiti J J Chir (Paris); 2005; 142(3):132-49. PubMed ID: 16142076 [TBL] [Abstract][Full Text] [Related]
12. Symptomatic presentation as a predictor of recurrence in gastroenteropancreatic neuroendocrine tumors: A single institution experience over 15 years. Baptiste GG; Postlewait LM; Ethun CG; Le N; McInnis MR; Russell MC; Winer JH; Kooby DA; Staley CA; Maithel SK; Cardona K J Surg Oncol; 2016 Aug; 114(2):163-9. PubMed ID: 27157897 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms. Attili F; Capurso G; Vanella G; Fuccio L; Delle Fave G; Costamagna G; Larghi A Dig Liver Dis; 2014 Jan; 46(1):9-17. PubMed ID: 23731843 [TBL] [Abstract][Full Text] [Related]
15. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors. Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823 [TBL] [Abstract][Full Text] [Related]
16. Pediatric gastroenteropancreatic neuroendocrine tumor: A case report and review of the literature. Gaiani F; de'Angelis N; Minelli R; Kayali S; Carra MC; de'Angelis GL Medicine (Baltimore); 2019 Sep; 98(37):e17154. PubMed ID: 31517859 [TBL] [Abstract][Full Text] [Related]
17. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636 [TBL] [Abstract][Full Text] [Related]
19. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604 [TBL] [Abstract][Full Text] [Related]
20. Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes Database. Chan H; Zhang L; Choti MA; Kulke M; Yao JC; Nakakura EK; Bloomston M; Benson AB; Shah MH; Strosberg JR; Bergsland EK; Van Loon K Pancreas; 2021 Apr; 50(4):506-512. PubMed ID: 33939661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]